Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
GE HealthCare Technologies logo

GE HealthCare Technologies Cash Flow Statement

Operating, investing, and financing cash movements

GE HealthCare Technologies generated $2.0B in operating cash flow over the trailing twelve months. After $508.0M in capital expenditures, free cash flow was $1.5B. Free cash flow decreased 0.2% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$2.0BNet Cash From Investing (TTM)-$3.1BNet Cash From Financing (TTM)$712.0MCapital Expenditures (TTM)$508.0MDepreciation And Amortization Cf (TTM)$299.0MNet Change In Cash (TTM)-$188.0M
Latest FilingQ1 2026
Report Date2026-04-29
Market Cap$29.3B
P/E Ratio15.36
ROE19.24%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$54M$269M$10M$0$99M$2.3B
Capital expenditures$102M$152M$86M$110M$134M$178M
Payment for (Proceeds from) Other Investing Activity$77M-$34M$118M——$13M
Net cash from investing activities-$240M-$407M-$223M-$148M-$269M-$2.5B
Other investing activities$77M-$34M$118M——$13M
Purchases of investments$7M$20M$8M$54M$36M$13M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Amortization of intangible assets$75M$70M$75M$74M$72M$75M
Change in accounts payable$127M$146M-$259M-$6M$209M$221M
Change in accrued liabilities$136M-$200M-$7M$178M$123M-$250M
Change in deferred revenue$93M-$68M$45M$24M$80M$35M
Change in inventories—$154M$34M$29M—$171M
Other working capital changes-$26M-$101M-$117M—-$68M-$99M
Change in receivables$258M-$81M-$104M$191M$210M-$141M
Deferred income taxes$96M$104M$113M$179M$219M$94M
Depreciation and amortization$65M$66M$72M$75M$74M$78M
Net cash from operating activities$913M$250M$94M$593M$1.1B$290M
Net income$738M$588M$500M$464M$602M$411M
Amortization of capitalized software and acquired intangible assets$75M$70M$75M$74M$72M$75M
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain$0$97M$0$0$0$0
Depreciation$65M$66M$72M$75M$74M$78M
Increase (Decrease) in Accounts and Other Receivables$258M-$81M-$104M$191M$210M-$141M
Increase (Decrease) In Contract With Customer, Asset And Deferred Costs-$36M-$52M$100M$63M—$46M
Accrued compensation and employee benefits$136M-$200M-$7M$178M$123M-$250M
Pension and other postretirement income-$86M-$70M-$68M-$70M-$59M-$47M
Pension and Other Postretirement Benefits Expense, Employer Contribution, Cost$75M$98M$84M$78M$78M$97M
Pension and postretirement benefit expense-$86M-$70M-$68M-$70M-$59M-$47M
Stock-based compensation$33M$22M$34M$38M$36M$35M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from issuance of debt$1M$0$1.5B$1M$1.2B$1.2B
Repayments of debt$1.3B$257M$4M$4M$1.5B$1B
Dividends paid$14M$16M$16M$16M$16M$16M
Proceeds from debt with original maturities of more than three months$1M$0$1.5B$1M$1.2B$1.2B
Proceeds from exercises of stock options and other stock issuances$2M$20M$1M$4M$12M$10M
Other, net-$6M-$6M-$9M-$41M-$25M-$2M
Short-term borrowings/(repayments) less than 90 days — net$0$1M———-$1M
Repayments Of Debt Maturing In More Than Three Months$1.3B$257M$4M$4M$1.5B$1B
Net cash from financing activities-$1.3B-$286M$1.4B——$21M
Other financing activities-$6M-$6M-$9M-$41M-$25M-$2M
Repurchases of common stock$0$0$100M$100M$0$100M
Net change in short-term borrowings$0$1M———-$1M
Taxes paid for net share settlement$3M$28M$5M$8M$1M$19M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$811M$98M$8M$483M$916M$112M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$75M$27M$57M——-$37M
Net increase (decrease) in cash—-$416M$1.3B$264M$486M-$2.2B

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$116M$91M$179M$83M$76M$92M
Interest paid$211M$78M$182M$67M$195M$87M
Income Taxes Paid, Net$116M$91M$179M$83M$76M$92M